PharmaCyte Biotech Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CITADEL ADVISORS LLC | 09/02/2026 | 283.38 K | $218.20 K | -21.18% | 4.04% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 124.25 K | $95.68 K | -36.50% | 1.77% |
| CITADEL ADVISORS LLC | 09/02/2026 | 86.10 K | $66.30 K | -46.25% | 1.23% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 56.78 K | $43.72 K | 10.32% | 0.81% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 44.85 K | $34.54 K | 100.00% | 0.64% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2026 | 37.99 K | $29.25 K | -32.77% | 0.54% |
| XTX TOPCO LTD | 08/14/2026 | 34.18 K | $26.32 K | -34.72% | 0.49% |
| NORTHERN TRUST CORP | 08/13/2026 | 32.62 K | $25.12 K | -8.36% | 0.47% |
| JANE STREET GROUP, LLC | 08/14/2026 | 30.06 K | $23.15 K | 160.75% | 0.43% |
| SCHONFELD STRATEGIC ADVISORS LLC | 08/14/2026 | 26.93 K | $20.73 K | -0.31% | 0.38% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 23.45 K | $18.06 K | 0.00% | 0.33% |
| EQUITEC PROPRIETARY MARKETS, LLC | 07/20/2026 | 22.23 K | $17.12 K | 0.00% | 0.32% |
| COMMONWEALTH EQUITY SERVICES, LLC | 07/29/2026 | 20.26 K | $15.60 K | 96.40% | 0.29% |
| HRT FINANCIAL LP | 08/14/2026 | 15.45 K | $11.00 K | -37.55% | 0.22% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/11/2026 | 4.89 K | $3.76 K | -0.02% | 0.07% |
| UBS GROUP AG | 08/13/2026 | 4.14 K | $3.19 K | -8.34% | 0.06% |
| GROUP ONE TRADING, L.P. | 08/14/2026 | 500 | $385 | -71.99% | 0.01% |
| ADVISOR GROUP HOLDINGS, INC. | 08/14/2026 | 303 | $232 | 0.33% | 0.00% |
| BARCLAYS PLC | 08/14/2026 | 192 | $148 | 100.00% | 0.00% |
| SACHETTA, LLC | 07/15/2026 | 14 | $11 | 0.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 07/23/2026 | 6 | $5 | 100.00% | 0.00% |
| BFSG, LLC | 07/20/2026 | 5 | $4 | 0.00% | 0.00% |
| MORGAN STANLEY | 08/13/2026 | 2 | $2 | 100.00% | 0.00% |
| FINANCIAL CONSULATE, INC | 07/23/2026 | 2 | $2 | 0.00% | 0.00% |
| NEWEDGE ADVISORS, LLC | 08/12/2026 | 2 | $2 | 0.00% | 0.00% |
| JOHNSON FINANCIAL GROUP, INC. | 08/10/2026 | 1 | $1 | 0.00% | 0.00% |
| MCF ADVISORS LLC | 08/12/2026 | 1 | $1 | 0.00% | 0.00% |
| BLACKROCK, INC. | 08/07/2026 | 1 | $1 | 0.00% | 0.00% |
| TWO SIGMA SECURITIES, LLC | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| SIMPLEX TRADING, LLC | 08/12/2026 | 0 | $0 | -100.00% | 0.00% |
| VIRTU FINANCIAL LLC | 08/13/2026 | 0 | $0 | -100.00% | 0.00% |
| GROUND SWELL CAPITAL, LLC | 08/05/2026 | 0 | $0 | -100.00% | 0.00% |
| WESTERN WEALTH MANAGEMENT, LLC | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| ABOUND WEALTH MANAGEMENT | 07/10/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
PharmaCyte Biotech Inc institutional Ownership - FAQ's
During the previous two years, 40 institutional investors and hedge funds held shares of PharmaCyte Biotech Inc. The most heavily invested institutionals were:
CITADEL ADVISORS LLC: 283,381
GEODE CAPITAL MANAGEMENT, LLC: 124,247
VANGUARD CAPITAL MANAGEMENT LLC: 56,778
SUSQUEHANNA INTERNATIONAL GROUP, LLP: 44,853
RENAISSANCE TECHNOLOGIES LLC: 37,987
XTX Topco Ltd: 34,180
10.87% of PharmaCyte Biotech Inc stock is owned by institutional investors.
Institutional investors have bought a total of 943.00 K shares in the last 24 months. This purchase volume represents approximately $660.10 K in transactions.